Interestingly, these findings were consistent in all subgroups evaluated, including also in those with and without established diabetes or prior CHD, in those with higher or lower plasma NT-proBNP, and in those with preserved or reduced LV-ejection fraction at baseline. The gene discussed is NPPB; the disease is diabetes mellitus.